Michael D. Mulholland
2014 - CytoDyn
In 2014, Michael D. Mulholland earned a total compensation of $380.1K as Chief Financial Officer at CytoDyn, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $92,500 |
|---|---|
| Option Awards | $54,494 |
| Salary | $225,000 |
| Other | $8,063 |
| Total | $380,057 |
Mulholland received $225K in salary, accounting for 59% of the total pay in 2014.
Mulholland also received $92.5K in bonus, $54.5K in option awards and $8.1K in other compensation.
Rankings
In 2014, Michael D. Mulholland's compensation ranked 11,132nd out of 13,032 executives tracked by ExecPay. In other words, Mulholland earned more than 14.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,132 out of 13,032 | 15th |
Division Manufacturing | 4,262 out of 4,966 | 14th |
Major group Chemicals And Allied Products | 1,471 out of 1,686 | 13th |
Industry group Drugs | 1,186 out of 1,365 | 13th |
Industry Pharmaceutical Preparations | 912 out of 1,043 | 13th |
Source: SEC filing on February 18, 2016.
Mulholland's colleagues
We found one more compensation record of an executive who worked with Michael D. Mulholland at CytoDyn in 2014.
2014
Nader Pourhassan
CytoDyn